|Chemical and physical data|
|Molar mass||354.44 g/mol g·mol−1|
|3D model (JSmol)|
AM-1714 (part of the AM cannabinoid series) is a drug that acts as a reasonably selective agonist of the peripheral cannabinoid receptor CB2, with sub-nanomolar affinity and 490x selectivity over the related CB1 receptor. In animal studies it has both analgesic and anti-allodynia effects. The 9-methoxy derivative AM-1710 has similar CB2 affinity but only 54x selectivity over CB1.
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|